459 related articles for article (PubMed ID: 31495567)
1. Maintenance antisepsis in reducing the rate of late-onset central venous catheter-related bloodstream infection: A comparison of 0.05% and 1% chlorhexidine.
Kikuchi M; Sato T; Okada S; Abe N; Sato A; Suzuki Y
J Infect Chemother; 2020 Feb; 26(2):188-193. PubMed ID: 31495567
[TBL] [Abstract][Full Text] [Related]
2. Skin antisepsis for reducing central venous catheter-related infections.
Lai NM; Lai NA; O'Riordan E; Chaiyakunapruk N; Taylor JE; Tan K
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010140. PubMed ID: 27410189
[TBL] [Abstract][Full Text] [Related]
3. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
Lorente L; Lecuona M; Jiménez A; Raja L; Cabrera J; Gonzalez O; Diosdado S; Marca L; Mora ML
Am J Infect Control; 2016 Jan; 44(1):50-3. PubMed ID: 26412482
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.
Garland JS; Alex CP; Mueller CD; Otten D; Shivpuri C; Harris MC; Naples M; Pellegrini J; Buck RK; McAuliffe TL; Goldmann DA; Maki DG
Pediatrics; 2001 Jun; 107(6):1431-6. PubMed ID: 11389271
[TBL] [Abstract][Full Text] [Related]
5. Targeting zero catheter-related bloodstream infections in pediatric intensive care unit: a retrospective matched case-control study.
Biasucci DG; Pittiruti M; Taddei A; Picconi E; Pizza A; Celentano D; Piastra M; Scoppettuolo G; Conti G
J Vasc Access; 2018 Mar; 19(2):119-124. PubMed ID: 29148002
[TBL] [Abstract][Full Text] [Related]
6. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
Lorente L; Lecuona M; Jiménez A; Cabrera J; Santacreu R; Lorenzo L; Raja L; Mora ML
Am J Infect Control; 2016 Dec; 44(12):1526-1529. PubMed ID: 27378009
[TBL] [Abstract][Full Text] [Related]
7. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites.
Lorente L; Lecuona M; Jiménez A; Lorenzo L; Santacreu R; Ramos S; Hurtado E; Buitrago M; Mora ML
Am J Infect Control; 2015 Jul; 43(7):711-4. PubMed ID: 25934065
[TBL] [Abstract][Full Text] [Related]
8. Comparative Efficacy of Antimicrobial Central Venous Catheters in Reducing Catheter-Related Bloodstream Infections in Adults: Abridged Cochrane Systematic Review and Network Meta-Analysis.
Chong HY; Lai NM; Apisarnthanarak A; Chaiyakunapruk N
Clin Infect Dis; 2017 May; 64(suppl_2):S131-S140. PubMed ID: 28475779
[TBL] [Abstract][Full Text] [Related]
9. One percent chlorhexidine-alcohol for preventing central venous catheter-related infection during intensive chemotherapy for patients with haematologic malignancies.
Ohtake S; Takahashi H; Nakagawa M; Uchino Y; Miura K; Iriyama N; Nakayama T; Hatta Y; Takei M
J Infect Chemother; 2018 Jul; 24(7):544-548. PubMed ID: 29627326
[TBL] [Abstract][Full Text] [Related]
10. Chlorhexidine-impregnated dressing for the prophylaxis of central venous catheter-related complications: a systematic review and meta-analysis.
Wei L; Li Y; Li X; Bian L; Wen Z; Li M
BMC Infect Dis; 2019 May; 19(1):429. PubMed ID: 31096918
[TBL] [Abstract][Full Text] [Related]
11. Comparison of four skin preparation strategies to prevent catheter-related infection in intensive care unit (CLEAN trial): a study protocol for a randomized controlled trial.
Goudet V; Timsit JF; Lucet JC; Lepape A; Balayn D; Seguin S; Mimoz O
Trials; 2013 Apr; 14():114. PubMed ID: 23782845
[TBL] [Abstract][Full Text] [Related]
12. Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability.
Montecalvo MA; McKenna D; Yarrish R; Mack L; Maguire G; Haas J; DeLorenzo L; Dellarocco N; Savatteri B; Rosenthal A; Watson A; Spicehandler D; Shi Q; Visintainer P; Wormser GP
Am J Med; 2012 May; 125(5):505-11. PubMed ID: 22482848
[TBL] [Abstract][Full Text] [Related]
13. Comparison of alcoholic chlorhexidine and povidone-iodine cutaneous antiseptics for the prevention of central venous catheter-related infection: a cohort and quasi-experimental multicenter study.
Pages J; Hazera P; Mégarbane B; du Cheyron D; Thuong M; Dutheil JJ; Valette X; Fournel F; Mermel LA; Mira JP; Daubin C; Parienti JJ;
Intensive Care Med; 2016 Sep; 42(9):1418-26. PubMed ID: 27311311
[TBL] [Abstract][Full Text] [Related]
14. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs.
Lorente L; Lecuona M; Jiménez A; Santacreu R; Raja L; Gonzalez O; Mora ML
Am J Infect Control; 2014 Mar; 42(3):321-4. PubMed ID: 24581021
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of care bundles with chlorhexidine dressing and advanced dressings to prevent catheter-related bloodstream infections in pediatric hematology-oncology patients.
Gerçeker GÖ; Yardımcı F; Aydınok Y
Eur J Oncol Nurs; 2017 Jun; 28():14-20. PubMed ID: 28478850
[TBL] [Abstract][Full Text] [Related]
16. Effect of ultrasound-guided central venous catheter insertion on the incidence of catheter-related bloodstream infections and mechanical complications.
Imataki O; Shimatani M; Ohue Y; Uemura M
BMC Infect Dis; 2019 Oct; 19(1):857. PubMed ID: 31619174
[TBL] [Abstract][Full Text] [Related]
17. Strategies for the prevention of central venous catheter infections: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review.
Huang EY; Chen C; Abdullah F; Aspelund G; Barnhart DC; Calkins CM; Cowles RA; Downard CD; Goldin AB; Lee SL; St Peter SD; Arca MJ;
J Pediatr Surg; 2011 Oct; 46(10):2000-11. PubMed ID: 22008341
[TBL] [Abstract][Full Text] [Related]
18. A daily topical decontamination regimen reduces catheter-related bloodstream infections in haematology patients.
Samuelson C; Kaur H; Kritsotakis EI; Goode SD; Nield A; Partridge D
J Infect; 2018 Feb; 76(2):132-139. PubMed ID: 29126814
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection.
Humar A; Ostromecki A; Direnfeld J; Marshall JC; Lazar N; Houston PC; Boiteau P; Conly JM
Clin Infect Dis; 2000 Oct; 31(4):1001-7. PubMed ID: 11049783
[TBL] [Abstract][Full Text] [Related]
20. Minimising central line-associated bloodstream infection rate in inserting central venous catheters in the adult intensive care units.
Hina HR; McDowell JRS
J Clin Nurs; 2017 Dec; 26(23-24):3962-3973. PubMed ID: 28334482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
